Diagnostic Distinction of Malignant Melanoma and Benign Nevi by a Gene Expression Signature and Correlation to Clinical Outcomes-Reference-Cited by-同舟云学术

Diagnostic Distinction of Malignant Melanoma and Benign Nevi by a Gene Expression Signature and Correlation to Clinical Outcomes

Published:2017-04-04 Issue:7 Volume:26 Page:1107-1113
ISSN:1055-9965
Container-title:Cancer Epidemiology Biomarkers & Prevention
language:en
Short-container-title:Cancer Epidemiol Biomarkers Prev

Author:

Ko Jennifer S.,Matharoo-Ball Balwir,Billings Steven D.,Thomson Brian J.,Tang Jean Y.,Sarin Kavita Y.,Cai Emily,Kim Jinah,Rock Colleen,Kimbrell Hillary Z.,Flake Darl D.,Warf M. Bryan,Nelson Jonathan,Davis Thaylon,Miller Catherine,Rushton Kristen,Hartman Anne-Renee,Wenstrup Richard J.,Clarke Loren E.

Publisher

American Association for Cancer Research (AACR)

Subject

Oncology,Epidemiology

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Appropriate Statistical Methods to Assess Cross-study Diagnostic 23-Gene Expression Profile Test Performance for Cutaneous Melanocytic Neoplasms;The American Journal of Dermatopathology;2024-08-14

2. A clinical impact study of dermatologists' use of diagnostic gene expression profile testing to guide patient management;Melanoma Management;2024-04-18

3. Diagnostic utility of the 23-gene expression profile test for an atypical intradermal melanocytic proliferation;Personalized Medicine;2024-01

4. Advances in melanoma: epidemiology, diagnosis, and prognosis;Frontiers in Medicine;2023-11-22

5. Cutaneous Melanoma: A Review of Multifactorial Pathogenesis, Immunohistochemistry, and Emerging Biomarkers for Early Detection and Management;International Journal of Molecular Sciences;2023-11-01